Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

Al B. Benson; Michael I. D'Angelica; Daniel E. Abbott; Thomas A. Abrams; Steven R. Alberts; Daniel Anaya Saenz; Chandrakanth Are; Daniel B. Brown; Daniel T. Chang; Anne M. Covey; William Hawkins; Renuka Iyer; Rojymon Jacob; Andrea Karachristos; R. Kate Kelley; Robin Kim; Manisha Palta; James O. Park; Vaibhav Sahai; Tracey Schefter; Carl Schmidt; Jason K. Sicklick; Gagandeep Singh; Davendra Sohal; Stacey Stein; G. Gary Tian; Jean Nicolas Vauthey; Alan P. Venook; Andrew X. Zhu; Karin G. Hoffmann; Susan Darlow

doi:10.6004/jnccn.2017.0059

Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

Al B. Benson
, Michael I. D'Angelica
, Daniel E. Abbott
, Thomas A. Abrams
, Steven R. Alberts
, Daniel Anaya Saenz
, Chandrakanth Are
, Daniel B. Brown
, Daniel T. Chang
, Anne M. Covey
, William Hawkins
, Renuka Iyer
, Rojymon Jacob
, Andrea Karachristos
, R. Kate Kelley
, Robin Kim
, Manisha Palta
, James O. Park
, Vaibhav Sahai
, Tracey Schefter

Carl Schmidt, Jason K. Sicklick, Gagandeep Singh, Davendra Sohal, Stacey Stein, G. Gary Tian, Jean Nicolas Vauthey, Alan P. Venook, Andrew X. Zhu, Karin G. Hoffmann, Susan Darlow

Research output: Contribution to journal › Review article › peer-review

301 Scopus citations

Abstract

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

Original language	English
Pages (from-to)	563-573
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2017.0059
State	Published - May 1 2017

Access to Document

10.6004/jnccn.2017.0059

Cite this

Benson, A. B., D'Angelica, M. I., Abbott, D. E., Abrams, T. A., Alberts, S. R., Saenz, D. A., Are, C., Brown, D. B., Chang, D. T., Covey, A. M., Hawkins, W., Iyer, R., Jacob, R., Karachristos, A., Kelley, R. K., Kim, R., Palta, M., Park, J. O., Sahai, V., ... Darlow, S. (2017). Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 15(5), 563-573. https://doi.org/10.6004/jnccn.2017.0059

@article{1003c80abaa24f4d88f960288140f665,

title = "Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.",

author = "Benson, \{Al B.\} and D'Angelica, \{Michael I.\} and Abbott, \{Daniel E.\} and Abrams, \{Thomas A.\} and Alberts, \{Steven R.\} and Saenz, \{Daniel Anaya\} and Chandrakanth Are and Brown, \{Daniel B.\} and Chang, \{Daniel T.\} and Covey, \{Anne M.\} and William Hawkins and Renuka Iyer and Rojymon Jacob and Andrea Karachristos and Kelley, \{R. Kate\} and Robin Kim and Manisha Palta and Park, \{James O.\} and Vaibhav Sahai and Tracey Schefter and Carl Schmidt and Sicklick, \{Jason K.\} and Gagandeep Singh and Davendra Sohal and Stacey Stein and Tian, \{G. Gary\} and Vauthey, \{Jean Nicolas\} and Venook, \{Alan P.\} and Zhu, \{Andrew X.\} and Hoffmann, \{Karin G.\} and Susan Darlow",

year = "2017",

month = may,

day = "1",

doi = "10.6004/jnccn.2017.0059",

language = "English",

volume = "15",

pages = "563--573",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "5",

}

Benson, AB, D'Angelica, MI, Abbott, DE, Abrams, TA, Alberts, SR, Saenz, DA, Are, C, Brown, DB, Chang, DT, Covey, AM, Hawkins, W, Iyer, R, Jacob, R, Karachristos, A, Kelley, RK, Kim, R, Palta, M, Park, JO, Sahai, V, Schefter, T, Schmidt, C, Sicklick, JK, Singh, G, Sohal, D, Stein, S, Tian, GG, Vauthey, JN, Venook, AP, Zhu, AX, Hoffmann, KG & Darlow, S 2017, 'Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 5, pp. 563-573. https://doi.org/10.6004/jnccn.2017.0059

TY - JOUR

T1 - Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

AU - Benson, Al B.

AU - D'Angelica, Michael I.

AU - Abbott, Daniel E.

AU - Abrams, Thomas A.

AU - Alberts, Steven R.

AU - Saenz, Daniel Anaya

AU - Are, Chandrakanth

AU - Brown, Daniel B.

AU - Chang, Daniel T.

AU - Covey, Anne M.

AU - Hawkins, William

AU - Iyer, Renuka

AU - Jacob, Rojymon

AU - Karachristos, Andrea

AU - Kelley, R. Kate

AU - Kim, Robin

AU - Palta, Manisha

AU - Park, James O.

AU - Sahai, Vaibhav

AU - Schefter, Tracey

AU - Schmidt, Carl

AU - Sicklick, Jason K.

AU - Singh, Gagandeep

AU - Sohal, Davendra

AU - Stein, Stacey

AU - Tian, G. Gary

AU - Vauthey, Jean Nicolas

AU - Venook, Alan P.

AU - Zhu, Andrew X.

AU - Hoffmann, Karin G.

AU - Darlow, Susan

PY - 2017/5/1

Y1 - 2017/5/1

N2 - The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

AB - The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

UR - https://www.scopus.com/pages/publications/85019124015

U2 - 10.6004/jnccn.2017.0059

DO - 10.6004/jnccn.2017.0059

M3 - Review article

C2 - 28476736

AN - SCOPUS:85019124015

SN - 1540-1405

VL - 15

SP - 563

EP - 573

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 5

ER -

Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this